Trevi Therapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Trevi Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from 2018 to 2023.
  • Trevi Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $11K, a 15.4% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Depreciation for 2023 was $81K, a 88.4% increase from 2022.
  • Trevi Therapeutics, Inc. annual Depreciation for 2022 was $43K, a 14% decline from 2021.
  • Trevi Therapeutics, Inc. annual Depreciation for 2021 was $50K, a 6.38% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $81K +$38K +88.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $43K -$7K -14% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $50K +$3K +6.38% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $47K +$8K +20.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $39K +$16K +69.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $23K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.